- July 14, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") , a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that it has received its production run of approximately 20,000 units of its BPC-157 transdermal patch (the "Patch"), the Company's lead product candidate
The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations
Read More Learn about the causes and treatments of atrial fibrillation, as well as the therapies and medications necessary for the treatment of heart afib
Enhanced Nrf2 Expression Mitigates the Decline in Neural Stem Cell Function During a Critical Aging Period
Measured response: visceral fat by InBody, IGF-1, sleep quality, and body composition are tracked across the 3 month cycle
Most people produce L-Glutamine naturally as an amino acid